AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $14,017,000 | -25.8% | 499,000 | 0.0% | 0.46% | -19.3% |
Q2 2019 | $18,892,000 | -3.0% | 499,000 | 0.0% | 0.57% | -14.3% |
Q1 2019 | $19,471,000 | +232.1% | 499,000 | +81.5% | 0.67% | +157.7% |
Q4 2018 | $5,863,000 | -46.1% | 275,000 | 0.0% | 0.26% | -35.0% |
Q3 2018 | $10,887,000 | +3.6% | 275,000 | 0.0% | 0.40% | -8.3% |
Q2 2018 | $10,508,000 | +29.5% | 275,000 | +1.9% | 0.44% | +14.7% |
Q1 2018 | $8,114,000 | +15.4% | 270,000 | +20.0% | 0.38% | +3.5% |
Q4 2017 | $7,031,000 | +11.6% | 225,000 | 0.0% | 0.37% | +2.8% |
Q3 2017 | $6,302,000 | +46.4% | 225,000 | 0.0% | 0.36% | +33.2% |
Q2 2017 | $4,304,000 | +12.3% | 225,000 | 0.0% | 0.27% | +5.5% |
Q1 2017 | $3,834,000 | -6.7% | 225,000 | 0.0% | 0.25% | -4.9% |
Q4 2016 | $4,111,000 | +2.6% | 225,000 | 0.0% | 0.27% | +9.0% |
Q3 2016 | $4,007,000 | – | 225,000 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |